Gö6983 attenuates breast cancer‐induced osteolysis by the apoptotic pathway
- 8 December 2019
- journal article
- research article
- Published by Wiley in Cell Biology International
- Vol. 44 (3) , 838-847
Abstract
Bone metastasis caused by breast cancer leads to significant complications in treatment, and the resulting osteolysis considerably affects patients’ overall survival and quality of life. Gö6983 is a broad spectrum protein kinase C inhibitor. In this study, based on our finding that the Gö6983 inhibits osteolysis, we applied Gö6983 to the MDA‐MB‐231 breast cancer‐induced mouse bone metastasis model. And we found that Gö6983 has a strong inhibitory effect on the tumorigenic model of breast cancer by promoting the mitochondrial apoptosis pathway. Our study, therefore, demonstrates that Gö6983 has a potential inhibitory effect on breast cancer‐induced osteoclast activation and provides mechanistic insight that may prove useful for designing future treatments.Keywords
Funding Information
- Natural Science Foundation of Guangxi Province (2017GXNSFAA198258, 2017GXNSFBA198098)
This publication has 30 references indexed in Scilit:
- Mitochondrial superoxide mediates doxorubicin-induced keratinocyte apoptosis through oxidative modification of ERK and Bcl-2 ubiquitinationBiochemical Pharmacology, 2012
- Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in NeuroblastomaCancer Research, 2012
- The critical role of the bone microenvironment in cancer metastasesMolecular and Cellular Endocrinology, 2009
- The correlation of RANK, RANKL and TNFα expression with bone loss volume and polyethylene wear debris around hip implantsBiomaterials, 2006
- Crosstalk between cancer cells and bone microenvironment in bone metastasisBiochemical and Biophysical Research Communications, 2005
- Inhibition of L-Type Cav1.2 Ca2+ Channels by 2,(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl) Maleimide (Gö6983)Molecular Pharmacology, 2005
- Gö 6983 Exerts Cardioprotective Effects in Myocardial Ischemia/ReperfusionJournal of Cardiovascular Pharmacology, 2004
- Different Expression Patterns of Bcl-2, Bcl-xl, and Bax Proteins After Sublethal Forebrain Ischemia in C57Black/Crj6 Mouse StriatumStroke, 2003
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymesFEBS Letters, 1996